Private Harbour Investment Management & Counsel Position in Abbvie (ABBV) Cut by $1.51 Million as Share Price Rose; As Pfizer (PFE) Valuation Declined, Holder Nippon Life Insurance Company Trimmed Position

January 14, 2018 - By whatsonthorold

Nippon Life Insurance Company decreased its stake in Pfizer Inc (PFE) by 1.53% based on its latest 2017Q3 regulatory filing with the SEC. Nippon Life Insurance Company sold 18,907 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 1.22 million shares of the health care company at the end of 2017Q3, valued at $43.42M, down from 1.24M at the end of the previous reported quarter. Nippon Life Insurance Company who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $217.80 billion market cap company. The stock decreased 0.05% or $0.02 during the last trading session, reaching $36.54. About 19.20 million shares traded or 25.61% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since January 14, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Private Harbour Investment Management & Counsel Llc decreased its stake in Abbvie Inc (ABBV) by 54.22% based on its latest 2017Q3 regulatory filing with the SEC. Private Harbour Investment Management & Counsel Llc sold 17,138 shares as the company’s stock rose 6.17% with the market. The institutional investor held 14,471 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.29M, down from 31,609 at the end of the previous reported quarter. Private Harbour Investment Management & Counsel Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $160.19 billion market cap company. The stock increased 1.08% or $1.07 during the last trading session, reaching $100.34. About 4.37 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 14, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 30. They expect $0.56 EPS, up 19.15% or $0.09 from last year’s $0.47 per share. PFE’s profit will be $3.34B for 16.31 P/E if the $0.56 EPS becomes a reality. After $0.67 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -16.42% negative EPS growth.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.02, from 0.94 in 2017Q2. It is positive, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. 10.51M are held by California State Teachers Retirement System. Virtus Inv Advisers reported 26,250 shares. Mairs Pwr invested in 2.04% or 4.77 million shares. Barrington Strategic Wealth Management Ltd Com has 0.77% invested in Pfizer Inc. (NYSE:PFE). Crestpoint Cap Mngmt Limited Liability Com stated it has 21,600 shares or 0.34% of all its holdings. 283,273 are held by Oakbrook Invests Limited Liability Com. Fairview Capital Invest Management Ltd Liability Co holds 0.02% or 7,973 shares in its portfolio. 2.01M were reported by Pub Sector Pension Investment Board. Efg Asset Mgmt (Americas) has 0.3% invested in Pfizer Inc. (NYSE:PFE). Stearns Grp stated it has 0.34% in Pfizer Inc. (NYSE:PFE). Ccm Inv Advisers Ltd Liability Company holds 5,829 shares or 0.04% of its portfolio. Wolverine Asset Mgmt Ltd Liability Com holds 95,149 shares or 0.04% of its portfolio. Chesley Taft & Ltd Liability Corporation accumulated 225,539 shares. De Burlo Grp Inc invested in 0.05% or 6,957 shares. Bp Plc invested 0.88% in Pfizer Inc. (NYSE:PFE).

Among 21 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Pfizer had 67 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, August 1. The rating was maintained by Credit Suisse with “Outperform” on Monday, May 9. On Tuesday, October 20 the stock rating was upgraded by Cowen & Co to “Outperform”. The rating was upgraded by Morgan Stanley on Wednesday, September 20 to “Overweight”. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Thursday, July 13 with “Hold” rating. Barclays Capital upgraded Pfizer Inc. (NYSE:PFE) on Tuesday, November 29 to “Overweight” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Monday, June 20. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, November 3 by Argus Research. Jefferies maintained it with “Buy” rating and $42 target in Tuesday, June 14 report. The firm earned “Buy” rating on Wednesday, October 28 by Deutsche Bank.

Since August 4, 2017, it had 0 insider buys, and 10 insider sales for $16.36 million activity. Another trade for 7,350 shares valued at $249,900 was made by MACKENZIE ALEXANDER R on Friday, September 1. DAMELIO FRANK A also sold $3.21 million worth of Pfizer Inc. (NYSE:PFE) shares. Another trade for 96,950 shares valued at $3.30 million was made by READ IAN C on Friday, August 4. 38,230 shares valued at $1.34M were sold by SUSMAN SALLY on Tuesday, September 12. Another trade for 8,064 shares valued at $263,693 was sold by OLSON LAURIE J.

Nippon Life Insurance Company, which manages about $5.33B US Long portfolio, upped its stake in Red Hat Inc (NYSE:RHT) by 5,146 shares to 21,336 shares, valued at $2.37M in 2017Q3, according to the filing. It also increased its holding in Aon Plc (NYSE:AON) by 3,445 shares in the quarter, for a total of 5,192 shares, and has risen its stake in Servicenow Inc (NYSE:NOW).

Since July 31, 2017, it had 0 insider purchases, and 8 sales for $45.57 million activity. GONZALEZ RICHARD A also sold $6.24 million worth of AbbVie Inc. (NYSE:ABBV) shares. Shares for $8.57M were sold by RICHMOND TIMOTHY J.. 145,510 shares valued at $14.07M were sold by Schumacher Laura J on Thursday, December 14. 8,300 AbbVie Inc. (NYSE:ABBV) shares with value of $705,655 were sold by SALEKI-GERHARDT AZITA. Michael Robert A. sold $589,512 worth of AbbVie Inc. (NYSE:ABBV) on Thursday, September 28.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 70 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by SunTrust on Wednesday, July 22 with “Buy”. The stock has “Outperform” rating by Cowen & Co on Wednesday, October 11. UBS maintained the shares of ABBV in report on Friday, October 13 with “Neutral” rating. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Monday, December 7. Deutsche Bank maintained AbbVie Inc. (NYSE:ABBV) on Monday, July 17 with “Hold” rating. The rating was maintained by Jefferies with “Buy” on Monday, July 17. The firm has “Hold” rating by Credit Suisse given on Thursday, July 20. The firm earned “” rating on Monday, September 28 by Citigroup. Jefferies maintained it with “Buy” rating and $94.0 target in Friday, August 18 report. On Monday, October 16 the stock rating was maintained by SunTrust with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>